Eli Lilly and Company (LLY)

Eli Lilly Revenue

Eli Lilly had revenue of $22.97B in the quarter ending June 30, 2026, with 47.67% growth. This brings the company's total for the last twelve months to $79.67B, up 49.58% year-over-year. In the year 2025, Eli Lilly had annual revenue of $65.18B with 44.70% growth. That makes Eli Lilly the 141st largest company in the world by revenue and 58th in the United States.

• Revenue (ttm): $79.67B
• Revenue Growth: +49.58%
• P/S Ratio: 14.25
• Revenue / Employee: $1,593,320
• Employees: 50,000
• Market Cap: 1.14T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Mounjaro 22.97B 35.2%
• Zepbound Injectable 13.54B 20.8%
• Oncology 9.38B 14.4%
• Immunology 5.25B 8.1%
• Trulicity 4.28B 6.6%
• Jardiance 3.43B 5.3%
• Humalog 2.17B 3.3%
• Other 4.17B 6.4%

By Geography

Chart

• US 43.48B 66.7%
• Europe 11.56B 17.7%
• Other Foreign Countries 6.06B 9.3%
• Japan 2.13B 3.3%
• China 1.95B 3.0%

Fiscal year ended Dec 31, 2025 See the full Eli Lilly breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	65.18B	20.14B	44.70%
Dec 31, 2024	45.04B	10.92B	32.00%
Dec 31, 2023	34.12B	5.58B	19.56%
Dec 31, 2022	28.54B	223.00M	0.79%
Dec 31, 2021	28.32B	3.78B	15.40%
Dec 31, 2020	24.54B	2.22B	9.95%
Dec 31, 2019	22.32B	826.20M	3.84%
Dec 31, 2018	21.49B	1.52B	7.61%
Dec 31, 2017	19.97B	-1.25B	-5.88%
Dec 31, 2016	21.22B	1.26B	6.33%
Dec 31, 2015	19.96B	343.10M	1.75%
Dec 31, 2014	19.62B	-3.50B	-15.13%
Dec 31, 2013	23.11B	509.70M	2.25%
Dec 31, 2012	22.60B	-1.68B	-6.93%
Dec 31, 2011	24.29B	1.21B	5.25%
Dec 31, 2010	23.08B	1.24B	5.68%
Dec 31, 2009	21.84B	1.46B	7.19%
Dec 31, 2008	20.37B	1.74B	9.33%
Dec 31, 2007	18.63B	2.94B	18.75%
Dec 31, 2006	15.69B	1.05B	7.14%
Dec 31, 2005	14.65B	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error